News

CollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics

CollectiveMinds LLC, a leading executive search firm specializing in life sciences and healthcare, today announced the successful placement of Keith Meadors as Chief Commercial Officer of Genova Diagnostics, a pioneer in advanced diagnostic testing. The appointment marks another milestone for CollectiveMinds in connecting exceptional leadership talent with high-growth organizations across the diagnostics and life sciences sectors.

Meadors joins the company at a pivotal time as Genova continues to build on its momentum, expand its commercial capabilities, and strengthen its position in the diagnostic testing market. With more than 30 years of experience spanning clinical diagnostics, pharmaceuticals, and medical devices, he brings a distinguished track record of driving revenue growth, building high-performing commercial organizations, and aligning strategy with evolving healthcare demands.

Most recently, Meadors served as Vice President and General Manager at Labcorp, where he held full P&L accountability and overall leadership for the South Atlantic region. In that role, he led growth-focused strategies to deepen key customer partnerships, expand market share through innovative diagnostic offerings, and drive operational and organizational transformation to strengthen revenue performance, productivity, and customer experience.

Prior to Labcorp, Meadors held senior leadership roles at Precipio, Fresenius Kabi, Hospira (a Pfizer company), and Becton Dickinson. Throughout his career, he has consistently delivered results by aligning commercial strategy with evolving healthcare needs and fostering accountability across teams.

“From the outset, Keith demonstrated exactly the qualities that distinguish exceptional executive candidates — he arrived prepared, proactive, and deeply committed to the process. He consistently followed every engagement with detailed summary communications to both our team and the client, ensuring full alignment at every stage. Keith embodies what true executive readiness looks like, and we are proud to have placed a leader of his caliber with an organization as dynamic as Genova Diagnostics.”

— Tara Kochis, CEO, CollectiveMinds LLC

At Genova Diagnostics, Meadors will lead the company’s commercial organization, with responsibility for advancing growth strategy, strengthening customer relationships, and supporting the continued expansion of Genova’s market presence and diagnostic portfolio.

“Keith brings an exceptional combination of commercial leadership, operational discipline, and deep healthcare experience,” said Jeffrey Ledford, Chief Executive Officer of Genova Diagnostics. “As Genova continues to grow and evolve, we are excited to welcome a proven leader who understands how to build strong teams, create meaningful customer partnerships, and drive long-term value for the organization.”

The placement follows Genova’s acquisition of Cell Science Systems in January 2026, a strategic move that expanded the company’s position in the diagnostic testing market and broadened its opportunities for innovation and growth. Supported by ownership group Levine Leichtman Capital Partners, Genova continues to invest in the leadership and capabilities needed to execute on its next chapter.

“Genova Diagnostics has built a strong reputation for scientific rigor, innovation, and service,” said Meadors. “I’m honored to join the company at such an important time and look forward to working with the team to build on that foundation, expand our commercial impact, and help more customers access the value Genova brings to the market.”

Meadors holds a Master of Business Administration from Texas Christian University, is a Kellogg Scholar in Sales & Marketing through Northwestern University’s Kellogg School of Management, and earned a Bachelor of Science from North Carolina State University. He is also a certified medical technologist with the American Society for Clinical Pathology.

For more information about executive search services from CollectiveMinds LLC, visit collectivemindsllc.com. For information about Genova Diagnostics, visit gdx.net.

Read more here.

Recent News

08/04/2026

Capra advances domestic manufacturing of essential medicines with continued HHS support

Capra Biosciences, Inc., a biomanufacturing company leveraging modular, continuous bioreactor technology to enable flexible, cost-competitive domestic production of pharmaceutical ingredients, today announced continued progress under its project agreement with the Administration for Strategic Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS). The additional investment brings Capra’s total ASPR

07/30/2026

Governor Spanberger Announces $2.4 Million in Grants for Virginia’s Biomedical Innovation Ecosystem

Governor Abigail Spanberger today announced a $2.4 million investment in Virginia’s life sciences ecosystem through Virginia Catalyst’s highly competitive grant program. Virginia Catalyst was founded in 2013 as Virginia’s research consortium through the efforts of the Virginia General Assembly and five of Virginia’s premiere research institutions. These non-dilutive grants — funding that does not require

07/29/2026

Slone Partners Names Sona Stroud and Kim Wilson as Senior Partners

Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, today announced the appointments of Sona Stroud and Kim Wilson as Senior Partners. Stroud has been promoted to the role following nearly 15 years with the firm, while Wilson returns to the organization, further strengthening its leadership team with nearly 17 years